weight loss drug news today glp-1 october 2025 drugs leave users low on key nutrients, study finds GLP-1 RA Weight Loss Drugs

Myocardial Infarction Subtypes in Patients With Type 2 Diabetes Mellitus and the Effect of Liraglutide Therapy (from the LEADER Trial)

GLP-1 therapy is generally recommended for individuals diagnosed with type 2 diabetes who require additional glycemic control, patients with a body mass index (BMI) greater than 27, especially those with weight-related comorbidities, and those not achieving target blood glucose levels with metformin or other oral hypoglycemic agents

According to the 2023 ADA standards of care in diabetes (62)

When comparing is GLP-1 better than dieting, GLP-1 often shows better adherence because it reduces hunger and cravings, making weight loss more sustainable than strict calorie restriction alone

Clinical trial data from the STEP and SURMOUNT programs demonstrate that maximum weight loss typically occurs between 60-72 weeks of treatment, with most patients losing 1-2 pounds per week during the active weight loss phase